Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
3
×
startups
3
×
biogen
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
ipo
3
×
bio
covid
medicines
roundup
acquisitions
activity
announced
approvals
biogen
biotech
boost
ceo
clamped
collabs
companies
daniel
deal
delays
developing
economic
fast
fda
followed
genomics
gilead
gilead’s
haul
help
including
introduce
isn’t
led
life
lot
markets
month
new
oric’s
o’day
Language
unset
Current search:
ipo
×
startups
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M